Cardiovascular morbidity and mortality of the metabolic syndrome
Kotaro Obunai1, Sonal Jani, George D Dangas
1Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, 161 Fort Washington Avenue, HIP 5th Floor, New York, NY 10032, USA. ko2182@columbia.edu
Insights
Metabolic syndrome, linked to obesity, significantly increases cardiovascular disease risk. Early identification and management are crucial for preventing heart conditions and improving patient outcomes.
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Cardiovascular disease is the leading cause of death in the US.
- Obesity prevalence is rising, increasing focus on metabolic syndrome.
- Metabolic syndrome is associated with heightened cardiovascular disease risk.
Purpose of the Study:
- To review evidence on metabolic syndrome's impact on cardiovascular morbidity and mortality.
- To discuss cardiovascular risk assessment in patients with multiple risk factors.
- To explore clinical implications of diagnosing metabolic syndrome.
Main Methods:
- Review of longitudinal observational studies.
- Analysis of data on various population subsets.
- Evaluation of cardiovascular risk assessment strategies.
Main Results:
- Metabolic syndrome is a significant predictor of cardiovascular morbidity and mortality.
- Evidence supports the association across diverse populations.
- Current risk assessment tools need to account for metabolic syndrome.
Conclusions:
- Metabolic syndrome is a critical factor in cardiovascular disease.
- Risk stratification should incorporate metabolic syndrome diagnosis.
- Clinical management strategies must address metabolic syndrome to reduce cardiovascular events.
Abstract:
Cardiovascular disease remains the single leading cause of morbidity and mortality in the United States. The metabolic syndrome has received increased attention in recent years, partly because of the growing prevalence of obesity and its association with cardiovascular disease. This article reviews current evidence from longitudinal observational studies that evaluated the impact of metabolic syndrome on cardiovascular morbidity and mortality in various population subsets. The approach to cardiovascular risk assessment in individuals who have multiple risk factors and the clinical implications of diagnosing the metabolic syndrome are also discussed.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:19Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:26Type II Diabetes I: Introduction
01:24Type II Diabetes II: Pathophysiology
01:22Complications of Diabetes Mellitus
01:30Coronary Artery Disease III: Clinical Manifestations